肿瘤与皮质回声比值能否鉴别血管平滑肌脂肪瘤与其他高回声肾肿块
回顾性研究评估肿瘤与皮质回声比值(TCER)对高回声肾肿块的鉴别价值,共纳入65例患者70个肿块(49个血管平滑肌脂肪瘤)。TCER>2.26诊断血管平滑肌脂肪瘤的敏感度81.6%、特异度71.4%;TCER>3.98时特异度达100%、敏感度28.6%。
要点
- TCER>2.26鉴别血管平滑肌脂肪瘤与非血管平滑肌脂肪瘤:敏感度81.6%、特异度71.4%。
- TCER>3.98时诊断血管平滑肌脂肪瘤特异度100%、敏感度28.6%。
- TCER由肾肿块回声与相邻肾皮质回声的比值计算,使用的是市售软件。
核心结论
- 研究提示TCER可能有助于高回声肾肿块的定性鉴别。
研究设计与样本
- 回顾性研究,查询2012年至2014年放射学数据库,按既定纳入与排除标准筛选高回声肾肿块。
- 共纳入65例患者的70个肿块,其中49个为血管平滑肌脂肪瘤。
- 每个肿块按预设标准判定为血管平滑肌脂肪瘤或非血管平滑肌脂肪瘤。
- 使用市售软件计算每个肿块回声与相邻肾皮质回声的比值(TCER)。
关键影像表现/征象
- 高回声肾肿块中血管平滑肌脂肪瘤占49个,其余为非血管平滑肌脂肪瘤。
诊断标准与关键数值
- TCER>2.26诊断血管平滑肌脂肪瘤的敏感度81.6%、特异度71.4%。
- TCER>3.98诊断血管平滑肌脂肪瘤的敏感度28.6%、特异度100%。
临床应用与阅片要点
- 作者认为TCER可能是高回声肾肿块定性鉴别的有用工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A retrospective study was performed to evaluate the diagnostic value of tumor-to-cortex echogenicity ratio (TCER) in the characterization of hyper-echoic renal masses. The radiology database was queried between 2012 and 2014 for hyper-echoic renal masses on the basis of defined exclusion and inclusion criteria. Each included mass was characterized as either an angiomyolipoma (AML) or a non-AML based on pre-defined criteria. The ratio of renal mass echogenicity to that of adjacent renal cortex (TCER) was calculated for each mass using commercially available software. A total of 70 masses in 65 patients were identified, including 49 AMLs. TCER values >2.26 were associated with a sensitivity and specificity of 81.6% and 71.4%, respectively, for diagnosis of AML. Moreover, TCER values >3.98 resulted in 100% specificity for AML diagnosis with a sensitivity of 28.6%. These findings suggest that the TCER may be a valuable tool for the characterization of hyper-echoic renal masses.
引用
- Habibollahi P, Chauhan A, Sultan LR, et al. Can "Tumor-to-Cortex Echogenicity Ratio" Differentiate Angiomyolipomas from Other Hyper-Echoic Renal Masses. Ultrasound Med Biol. 2017. PMID: 28400076. doi:10.1016/j.ultrasmedbio.2017.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。